Correlation Between Revelation Biosciences and InVivo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and InVivo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and InVivo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and InVivo Therapeutics Holdings, you can compare the effects of market volatilities on Revelation Biosciences and InVivo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of InVivo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and InVivo Therapeutics.
Diversification Opportunities for Revelation Biosciences and InVivo Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Revelation and InVivo is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and InVivo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InVivo Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with InVivo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InVivo Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and InVivo Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and InVivo Therapeutics
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the InVivo Therapeutics. In addition to that, Revelation Biosciences is 2.21 times more volatile than InVivo Therapeutics Holdings. It trades about -0.06 of its total potential returns per unit of risk. InVivo Therapeutics Holdings is currently generating about 0.06 per unit of volatility. If you would invest 131.00 in InVivo Therapeutics Holdings on August 31, 2024 and sell it today you would earn a total of 7.00 from holding InVivo Therapeutics Holdings or generate 5.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 8.58% |
| Values | Daily Returns |
Revelation Biosciences vs. InVivo Therapeutics Holdings
Performance |
| Timeline |
| Revelation Biosciences |
| InVivo Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Revelation Biosciences and InVivo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and InVivo Therapeutics
The main advantage of trading using opposite Revelation Biosciences and InVivo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, InVivo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InVivo Therapeutics will offset losses from the drop in InVivo Therapeutics' long position.| Revelation Biosciences vs. Cue Biopharma | Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. Inhibrx | Revelation Biosciences vs. Molecular Partners AG |
| InVivo Therapeutics vs. Virax Biolabs Group | InVivo Therapeutics vs. Revelation Biosciences | InVivo Therapeutics vs. Kiora Pharmaceuticals | InVivo Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |